| Ticker Details |
|
Nuvalent, Inc.
|
| IPO Date: |
July 29, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$8.22B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.29 | 2.88%
|
| Avg Daily Range (30 D): |
$1.17 | 1.17%
|
| Avg Daily Range (90 D): |
$1.67 | 1.62%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.31M |
| Avg Daily Volume (30 D): |
.46M |
| Avg Daily Volume (90 D): |
.42M |
| Trade Size |
| Avg Trade Size (Sh.): |
47 |
| Avg Trade Size (Sh.) (30 D): |
47 |
| Avg Trade Size (Sh.) (90 D): |
45 |
| Institutional Trades |
| Total Institutional Trades: |
2,116 |
| Avg Institutional Trade: |
$3.35M |
| Avg Institutional Trade (30 D): |
$5.06M |
| Avg Institutional Trade (90 D): |
$5.59M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.21M |
| Avg Closing Trade (30 D): |
$8.17M |
| Avg Closing Trade (90 D): |
$8.31M |
| Avg Closing Volume: |
73.06K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-5.85
|
$-1.58
|
$-5.85
|
|
Diluted EPS
|
$-5.85
|
$-1.58
|
$-5.85
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-425.38M
|
$-118.71M
|
$-425.38M
|
|
Operating Income / Loss
|
$-414.31M
|
$-102.23M
|
$-414.31M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$116.05M
|
$145.99M
|
$116.05M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Mar 10, 2017
|
1:1200000
|
|
|
|